Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Jeanne Fabre

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
EU healthcare regulatory, EU regulatory, EU/UK regulatory
Office
Paris
Active in the record
2021 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPOM&APrivate Equity & BuyoutsVenture Capital & Growth
Sectors
Consumer & RetailFinancial ServicesHealthcare & Life Sciences
Jurisdictions
BelgiumCayman IslandsChinaFranceGermanyIrelandItalyUnited KingdomUnited States

Recent deals

24 announced deals in the record
Latham & Watkins Advises on Vaderis Therapeutics’ US$152 Million Series B Financing 24 Sept 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 152m life sciences regulatory
Latham Advises Enovis on Binding Offer to Acquire eCential Robotics 6 Sept 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP EUR 155m healthcare and life sciences regulatory Paris
Latham Advises Goldman Sachs Alternatives on Investment in Numantec 4 Aug 2026
Private Equity & Buyouts Healthcare & Life Sciences Latham & Watkins LLP healthcare and life sciences
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP life sciences and regulatory
Latham Advises on Financing for American Industrial Partners’ Completed US$1.272 Billion Acquisition of Avanos Medical, Inc. 30 Jul 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.27bn healthcare and life sciences
Latham Advises on Financing for American Industrial Partners’ US$1.272 Billion Acquisition of Avanos Medical, Inc. 9 Jul 2026
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 1.27bn healthcare and life sciences
Latham Advises CVC and GBL Consortium on €10.7 Billion Cash Tender Offer for Recordati Aimed at Delisting From Euronext Milan 25 May 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP EUR 10.7bn healthcare and life sciences
Latham & Watkins Advises on Medline’s Upsized Landmark US$7.2 Billion IPO 19 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 7.20bn ex-US regulatory
Latham & Watkins Advises Owlet on US$30 Million Class A Stock Offering After Advising on Exchange of Series A and Series B Warrants 23 Oct 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 30m regulatory matters
Latham & Watkins Advises Boston Scientific in Acquisition of SoniVie Ltd. 5 Mar 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 360m EU regulatory
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Jeanne Fabre is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 24 deals for Jeanne Fabre

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction